%0 Journal Article %J J Alzheimers Dis %D 2016 %T Longitudinal Memory Profiles in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease. %A Schubert, Samantha %A Leyton, Cristian E %A Hodges, John R %A Piguet, Olivier %K Alzheimer Disease %K Aniline Compounds %K Brain %K Diagnosis, Differential %K Disease Progression %K Executive Function %K Female %K Follow-Up Studies %K Frontotemporal Dementia %K Humans %K Longitudinal Studies %K Male %K Memory %K Middle Aged %K Neuropsychological Tests %K Positron-Emission Tomography %K Radiopharmaceuticals %K Thiazoles %X

BACKGROUND: Alzheimer's disease (AD) and behavioral-variant of frontotemporal dementia (bvFTD) can present with an overlapping neuropsychological profile, which often hinders their clinical differentiation.

OBJECTIVE: To compare changes over time in memory, general cognition tasks, and functional scales between bvFTD and AD.

METHODS: Consecutive cases diagnosed with probable bvFTD (nā€Š=ā€Š22) and typical AD (nā€Š=ā€Š31) with at least two clinical visits were selected. Of these, 13 (9 AD, 4 bvFTD) underwent Pittsburgh compound B PET scan, which supported the clinical diagnosis in all cases. Mixed-model regressions were used to estimate the differential rate of decline on selected tasks between cohorts.

RESULTS: Analyses demonstrated that, despite equivalent baseline performance, bvFTD patients experienced a more rapid functional deterioration and a steeper decline in global cognition than AD patients. At baseline, both groups were impaired on executive function and memory tasks compared to controls, but these deficits were more marked in the bvFTD group. In addition, performance on these domains continued to decline more rapidly in this group.

CONCLUSIONS: Neither the initial neuropsychological assessment nor projected performances can reliably distinguish the totality of bvFTD and AD individuals. Nevertheless, annual rates of progression on cognitive tasks provide valuable information and will potentially help establish the impact of future therapeutic treatments in these dementia syndromes.

%B J Alzheimers Dis %V 51 %P 775-82 %8 2016 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/26890749?dopt=Abstract %R 10.3233/JAD-150802